The Spanish network on Advanced therapies (TERAV) is borne with the aim of developing innovative approaches of gene and cell therapy that should facilitate: 1) Development of proof-of-concept clinical trials using innovative ATMPs generated in our country, and 2) Protection and transfer of our innovative therapies to the industry, ideally to companies capable of expanding them towards their approval in international Regulatory Agencies, facilitating the treatment of diseases with poor prognosis world-wide.
Company Details
- Address
- Murcia, Es
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Murcia
- Competitors
- Instituto de Terapia Regenerativa Tisular (ITRT), GENE VECTOR, Centro de Investigación Biomédica en Red CIBER, Terapias Avanzadas, S.A., Sociedad Española de Terapia Génica y Celular, Spanish Society of Regenerative Medicine and Cell Therapy, PETHEMA, CellBri, BIO CELL by Vetnil, Red de Terapia Celular.
Terav Questions
Terav's LinkedIn profile is https://es.linkedin.com/company/terav
Terav's industry is
Biotechnology Research
Terav's top competitors are
Instituto De Terapia Regenerativa Tisular (Itrt),
Gene Vector,
Centro De Investigación Biomédica En Red Ciber,
Terapias Avanzadas, S.a.,
Sociedad Española De Terapia Génica Y Celular,
Spanish Society Of Regenerative Medicine And Cell Therapy,
Pethema,
Cellbri,
Bio Cell By Vetnil,
Red De Terapia Celular.
Terav's categories are Biotechnology Research
